Physician reviewing testosterone lab results with a male patient at Prime Body Solutions

The Truth About Testosterone Therapy: What the Newest Research Actually Says

June 24, 20266 min read

MEN'S HEALTH • HORMONE OPTIMIZATION

The Truth About Testosterone Therapy: What the Newest Research Actually Says

Separating decades of locker-room myth from peer-reviewed evidence — including the landmark trial that just changed the FDA's mind.

If you've spent any time on the internet researching testosterone therapy, you've probably encountered two equally unhelpful camps: the influencers who treat it like a magic elixir that will turn you into a Greek statue overnight, and the alarmists who act like a single injection will detonate your heart. The truth, as usual, lives in the more boring neighborhood between them — and as of 2025, the science has finally moved in next door.

So let's do something radical for the internet. Let's look at what the actual studies say, with receipts. Pour yourself something with electrolytes (not the other thing) and let's talk about what testosterone replacement therapy, or TRT, really does to the male body.

First, What Is “Low T” — and Why Should You Care?

Testosterone is the hormone responsible for a lot of the things men quietly take for granted: muscle mass, bone density, red blood cell production, libido, mood stability, and the motivation to do literally anything before 10 a.m. After about age 30, the average man's testosterone declines roughly 1% per year. That doesn't sound like much, until you realize compounding interest works against you here just like it does in your retirement account — except the dividends are fatigue, brain fog, and a strange new emotional attachment to your couch.

Clinically, hypogonadism (the medical term for genuinely low testosterone) isn't diagnosed by vibes or a quiz on a supplement website. It requires both consistent symptoms and repeatedly low blood levels, typically confirmed on two separate early-morning lab draws. A 2025 narrative review of TRT in men aged 50 and above emphasizes this exact point: therapy is for men with documented deficiency and symptoms, not for anyone who simply wants to bench more than their brother-in-law.

The Big One: The TRAVERSE Trial and the Heart Question

For over a decade, the scariest sentence attached to testosterone was the FDA's black box warning suggesting it might raise the risk of heart attacks and strokes. That warning, added back in 2015, was based on fairly shaky observational data — but “might hurt your heart” is the kind of phrase that ends conversations quickly.

Enter the TRAVERSE trial, published in the New England Journal of Medicine in 2023. This was the cardiovascular safety study everyone had been demanding: 5,246 men aged 45 to 80, all of whom had low testosterone plus existing heart disease or high cardiovascular risk — essentially the highest-stakes population you could test. They were randomized to testosterone gel or placebo and followed for years.

The result: major adverse cardiac events occurred in 7.0% of the testosterone group versus 7.3% of the placebo group. In plain English, testosterone did not increase heart attacks, strokes, or cardiovascular death in the very men most likely to have one.

That finding was strong enough that in February 2025 the FDA issued class-wide labeling changes and removed the cardiovascular black box warning from all testosterone products. It's not often a federal agency looks at a decade of its own cautionary language and says “never mind” — but the data made the case.

Before you start celebrating with a third pre-workout, the fine print matters. The same FDA update added a new warning about modest increases in blood pressure, and TRAVERSE itself noted small upticks in atrial fibrillation, blood clots, and fractures. Translation: testosterone is reassuringly safe for the heart, but it is still a medication that deserves monitoring — not a vitamin gummy.

Beyond Libido: The Metabolic Surprise

Most men come in asking about energy and sex drive, and yes — the evidence supports improvements in both. But one of the most interesting findings of the last few years has nothing to do with the bedroom and everything to do with blood sugar.

The T4DM trial, published in The Lancet Diabetes & Endocrinology, followed more than 1,000 overweight men aged 50 to 74 who were at high risk for type 2 diabetes. Everyone was put on a structured lifestyle and weight-loss program; half also received testosterone. After two years, 21% of the placebo group had developed type 2 diabetes, compared with just 12% of the testosterone group — roughly a 40% relative reduction in new diabetes diagnoses, on top of diet and exercise.

The honest caveat: testosterone is not a substitute for the lifestyle work — the men in T4DM were all dieting and exercising. Think of it as a tailwind, not a teleporter. The hormone made the hard work pay off faster; it didn't replace the hard work.

What About Real-World Patients, Not Just Trials?

Randomized trials are the gold standard, but they live in a controlled bubble. To see how therapy behaves in the wild, a 2025 retrospective cohort study of more than 9,000 men tracked real patients on testosterone over time. The reassuring headline: when therapy is properly prescribed and monitored, the long-term safety and outcome profile holds up outside the rarefied air of a clinical trial.

The operative phrase there is “properly prescribed and monitored.” That means baseline labs, periodic checks of your hematocrit (testosterone can thicken your blood like gravy left on the stove), PSA monitoring for prostate health, and dose adjustments based on how you respond — not on what a stranger on a forum injected last Tuesday.

The Bottom Line

Here's the evolved, evidence-based summary that the 2025 research supports: for men with genuinely low testosterone and real symptoms, properly monitored TRT can improve sexual function, mood, muscle mass, and bone density, appears cardiovascularly safe even in high-risk men, and may even lower diabetes risk when paired with lifestyle changes. The decade-old heart scare has been formally retired by the FDA.

What it is not is a shortcut, a personality, or a substitute for sleep, protein, and resistance training. Testosterone optimization works best as one instrument in a well-conducted orchestra — not a one-man band playing kazoo at the gym.

Thinking testosterone might be part of your story? The only way to know is real lab work and a real conversation with a clinician who reads the studies, not just the supplement labels. At Prime Body Solutions, every hormone plan starts with comprehensive testing and physician oversight — because your physiology deserves a strategy, not a guess. Book your consultation today.

Medical disclaimer

This article is for educational purposes only and is not a substitute for individualized medical advice. Testosterone therapy is a prescription treatment with real risks and benefits that vary by patient. Always consult a qualified clinician before starting or stopping any hormone therapy.

Studies Referenced

Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med, 2023.

FDA. Class-Wide Labeling Changes for Testosterone Products (Boxed Warning Removal). February 2025.

Wittert G, et al. Testosterone to prevent or revert type 2 diabetes (T4DM). Lancet Diabetes Endocrinol, 2021.

Real-World Outcomes and Safety of Testosterone Therapy: Cohort of Over 9,000 Men. World J Mens Health, 2025.

Testosterone Replacement Therapy in Men Aged 50 and Above: A Narrative Review. 2025.

Dr. Cody Belkoff

Dr. Cody Belkoff

Dr. Belkoff is a board-certified medical practitioner specializing in hormone optimization, regenerative medicine, and peptide therapy. With over two decades of experience in integrative health, he helps patients restore balance, vitality, and long-term wellness through evidence-based, physician-guided protocols. At Prime Body Solutions, Dr. Belkoff combines the latest advances in metabolic medicine, peptide science, and preventive care to create individualized programs that help patients heal, perform, and age on their own terms.

Back to Blog